We serve Chemical Name:4-bromo-1-oxidopyridazin-1-ium CAS:5753-63-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-bromo-1-oxidopyridazin-1-ium
CAS.NO:5753-63-9
Synonyms:4-BROMOPYRIDAZIN-1-OXIDE;Pyridazine,4-bromo-,1-oxide;4-Brompyridazin-1-oxid;4-bromo-pyridazine 1-oxide
Molecular Formula:C4H3BrN2O
Molecular Weight:174.98300
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:282.506ºC at 760 mmHg
Density:1.873 g/cm3
Index of Refraction:
PSA:38.35000
Exact Mass:173.94300
LogP:1.27260
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-BROMOPYRIDAZIN-1-OXIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-pyridazine 1-oxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Brompyridazin-1-oxid Use and application,4-bromo-pyridazine 1-oxide technical grade,usp/ep/jp grade.
Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 4-bromo-1-oxidopyridazin-1-ium manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 4-bromo-1-oxidopyridazin-1-ium supplier According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. 4-bromo-1-oxidopyridazin-1-ium vendor At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up. 4-bromo-1-oxidopyridazin-1-ium factory ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.
